drugset / Trial / NCT05761795

Efficacy of IVMED-85 on Pediatric Myopia

NCT05761795 ↗

Phase 1/2 Not yet recruiting 216 enrolled iVeena Delivery Systems, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of a 1-year course of IVMED-85 eye drops for the treatment of pediatric myopia by assessing its safety effects on visual acuity and its effect on the change and/or progression of myopia. The main question\[s\] it aims to answer are: * Does IVMED 85 improve visual acuity * Does IVMED 85 slow or otherwise change the progression of myopia Participants will use eyedrops twice a day for one year. Researchers will compare IVMED 85 to a placebo.

Timeline

Start
2024-02
Primary completion
2026-05
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject IVMED-85 Unknown — Topical

Indications